AC710

• Description :

  AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFRα and PDGFRβ, respectively.

• UNSPSC :

  12352005

• Hazard Statement :

  H315, H317, H318, H334, H335, H341, H361, H370, H413

• Target :

  C-Kit; FLT3; PDGFR

• Type :

  Reference compound

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/AC710.html

• Purity :

  99.13

• Solubility :

  DMSO : 14 mg/mL (ultrasonic; warming)

• Smiles :

  O=C(C1=NC=C(OC2CC(C)(C)N(CC)C(C)(C)C2)C=C1)NC3=CC=C(NC(NC4=NOC(C(C)(C)C)=C4)=O)C=C3

• Molecular Formula :

  C31H42N6O4

• Molecular Weight :

  562.70

• Precautions :

  H315, H317, H318, H334, H335, H341, H361, H370, H413

• References & Citations :

  [1]Liu G, et al. Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases. ACS Med Chem Lett. 2012 Sep 24;3 (12) :997-1002.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  PDGFRα; PDGFRβ

• CAS Number :

  [1351522-04-7]